Tolero Pharmaceuticals toleropharmaceuticals.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Tolero Pharmaceuticals is a biotechnology company specializing in the research and development of therapeutic agents in the areas of oncology and hematological disorders. Tolero possesses drug discovery capabilities for kinase inhibitors and other drug targets. The company is developing a range of compounds including cyclin-dependent kinase 9 (CDK9) inhibitor alvocidib, which is under clinical development for hematologic malignancies.

Tolero Pharmaceuticals is a biotechnology company specializing in the research and development of therapeutic agents in the areas of oncology and hematological disorders. Tolero possesses drug discovery capabilities for kinase inhibitors and other dr...Show all

Company (Acquired)

Phone: 801-285-6003

Fax:

2975 Executive Parkway
Suite #320
Lehi, 84043
Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tolero Pharmaceuticals $25.7M Dec 21, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tolero Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors Jul 02, 2019 Dec 29, 2020 Patent
Combination therapies for treatment of cancer Mar 17, 2020 Nov 17, 2020 Patent
Pkm2 modulators and methods for their use Sep 26, 2019 Sep 08, 2020 Patent
Jak2 and alk2 inhibitors and methods for their use Dec 19, 2018 Aug 25, 2020 Patent
Combination therapies for treatment of cancer Oct 28, 2019 Jun 16, 2020 Patent
See all 38 patents